AwesomeCapital
Search This Blog
Thursday, January 30, 2020
Corcept Therapeutics reports preliminary Q4 results
Corcept Therapeutics (NASDAQ:
CORT
): Q4 Revenue of $87.9M (+31.6% Y/Y) in-line.
Cash and investments of $315.3M
Press Release
https://seekingalpha.com/news/3536595-corcept-therapeutics-reports-preliminary-q4-results
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.